The FDA has granted Dexcom premarket approval for a professional version of its continuous glucose monitor. The Dexcom G4 Platinum Professional system is designed to give patients access to unblinded feedback in real time, and records glucose readings for seven days, rather than the three days offered by similar devices on the market.

Related Summaries